Clinical trial
Risk Perception in Multiple Sclerosis
NCT05528666 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risk Perception in Multiple Sclerosis
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 9, 2021
- Completion date
- September 17, 2021
- Enrollment
- 4,361 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.